[Medications of wellbeing].
Farré
M
M
Hernández-López
C
C
Peiró
A M
AM
D000368:Aged; D000505:Alopecia / Q000188:drug therapy; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D011307:Drug Prescriptions; D004358:Drug Therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000188:drug therapy; D005260:Female; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D004366:Nonprescription Drugs; D009765:Obesity / Q000188:drug therapy; D000077403:Orlistat; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones
D019440:Anti-Obesity Agents; D004791:Enzyme Inhibitors; D007783:Lactones; D004366:Nonprescription Drugs; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011619:Psychotropic Drugs; D011687:Purines; D013450:Sulfones; D018120:Finasteride; D000077403:Orlistat; D000068677:Sildenafil Citrate